Sexual behavior, use of contraceptive methods and risk factors for HPV infections of students living in Central Italy: Implications for vaccination strategies

Journal of Preventive Medicine and Hygiene

Volumn 53, Issue 1, 2012, Pages 24-29

  Boccalini, S ^a   Tiscione, E ^a   Bechini, A ^a   Levi, M ^a   Mencacci, M ^a   Petrucci, F ^a   Bani Assad, G ^a   Santini, M G ^b   Bonanni, P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Local Health Unit of Florence   (Italy)

Author keywords

HPV; Risk factors; Sexual behaviour; Use of contraceptive methods; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CONDOM; CONTRACEPTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; STUDENT; UTERINE CERVIX CANCER; VACCINATION;

ADOLESCENT; ADOLESCENT BEHAVIOR; AGE DISTRIBUTION; CONDOMS; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; ITALY; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; QUESTIONNAIRES; SEX DISTRIBUTION; SEX EDUCATION; SEXUAL BEHAVIOR; SEXUAL PARTNERS; STUDENTS; UNSAFE SEX; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84862068933     PISSN: 11212233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Burchell AN, Winer RL, de Sanjosé S, et al. Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006;24:S3/52-61.
2. Veldhuijzen NJ, Snijders PJ, Reiss P, et al. Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis 2010;10:862-74.
3. Moscicki AB. HPV infections in adolescents. Dis Markers 2007;23:229-34.
4. Meeting of the Immunization Strategic Advisory Group of Experts, Graz, April 2007 - conclusions and recommendations. Wkly Epidemiol Rec 2007;82:181-93.
5. Centers for Disease Control and Prevention. Seaxually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002;51:1-78.
6. Consiglio Superiore di Sanità. Seduta XLVI dell'11 gennaio 2007. Available at: http://www.ministerosalute.it/imgs/C-17-pubblicazioni-600- allegato.pdf
7. Comunicato Ministero della Salute n. 34 del 9 Febbraio 2007. Turco L. L'Italia sarà il primo Paese europeo a vaccinare gratuitamente le giovani donne. Vaccine HPV contro cancro cervice uterina. Available at: www.ministerosalute.it [20 February 2007].
8. Conferenza Stato Regioni. Intesa del 20 dicembre 2007 tra il Ministero della Salute, le Regioni e le Province Autonome di Trento e Bolzano. Strategia per l'offerta attiva del vaccino contro l'infezione da HPV in Italia. Atti n. 264/CSR del 20/12/2007.
9. Istituto Superiore di Sanità, Reparto Epidemiologia delle Malattie Infettive del CNESPS, ISS e del Gruppo Sanità Pubblica del Coordinamento Interregionale della Prevenzione. Ricognizione delle decisioni regionali in merito alla vaccinazione anti-HPV e stato di avanzamento dei programmi vaccinali nelle regioni italiane a fine anno 2008. 2 July 2009. Available at http://www.epicentro.iss.it/focus/hpv/pdf/campagna-Hpv08.pdf.
10. Regione Toscana. DGR n. 1020 del 27/12/2007. Aggiornamento direttive regionali in materia di vaccinazioni. Revoca delibere n. 1249 del 24/11/2003, n. 379 del 7/3/2005 e n. 1060 del 10/10/2000. Modifica delibera n. 1386 del 17/12/2001. (Pubblicata sul B.U. n. 2 del 9/01/2008 Parte II).
11. Regione Toscana. DGR n. 856 del 27/10/2008: Recepimento dell'Intesa Stato, Regioni e Province Autonome del 20/12/2007 e approvazione del programma regionale di vaccinazione antipapillomavirus umano (HPV). Direttive alle Aziende USL.
12. Boccalini S, Bonanni P, Mencacci M, et al. Le abitudini sessuali e i fattori di rischio per l'infezione da HPV degli studenti di Infermieristica dell'Università di Firenze: uno studio pilota. 43° National Congress of SItI (Italian Society of Hygiene and Preventive Medicine and Public Health), Bari, Italy, 1-4 October 2008, p. 504.
13. Panatto D, Amicizia D, Lugarini J, et al. Sexual behaviour in Ligurian (Northern Italy) adolescents and young people: suggestions for HPV vaccination policies. Vaccine 2009;27:A6-10.
14. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002;29:725-35. (Pubitemid 35266418)
15. Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006;354:2645-54.
16. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004;82:454-61. (Pubitemid 38828432)
17. Hernandez BY, Wilkens LR, Zhu X, et al. Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis 2008;14:888-94. (Pubitemid 351838596)
18. Renzi C, Signorelli C, Zantedeschi E, et al. A possible "marker" for subsequent high risk sexual behaviour in young Italians. J Prev Med Hyg 2001;42:1-14.
19. Signorelli C, Colzani E. Age at first intercourse and HPV immunization. J Prev Med Hyg 2007;48:37-8. (Pubitemid 351158000)
20. Signorelli C, Pasquarella C, Limina RM, et al. Third Italian national survey on knowledge, attitudes, and sexual behaviour in relation to HIV/AIDS risk and the role of health education campaigns. Eur J Public Health 2006;16:498-504. (Pubitemid 44536008)
21. Kraft P. Age of first intercourse among Norvegian adolescent: a lifetime perspective. Soc Sci Med 1991;2:207-13.
22. Johnson AM, Wadsworth J, Wellings K, et al. Sexual attitudes and lifestyles. Oxford: Blackwell Scientific Press 1994.
23. Wellings K, Field J, Johnson AM, et al. Sexual behaviour in Britain. London: Penguin 1994.
24. Llavs I, Rodrigues LC, Weiss HA, et al. Factors associated with early sexual debut in Slovenia: result of a general population suney. Sex Transm Infect 2006;82:478-83. (Pubitemid 46025190)
25. Lewin B. The adolescent boy and girl: first and other early experience with intercourse from a representative sample of Swedish school adolescents. Arch Sex Behav 1982;11:417-29.
26. Crochard A, Luyts D, di Nicola S, et al. Self-reported sexual debut and behavior in young adults aged 18-24 years in seven European countries: implications for HPV vaccination programs. Gynecol Oncol. 2009;115:S7-14.
27. Ault KA, Future II Study Group. Effect of prophylactic human papillomavirus LI virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomized clinical trials. Lancet 2007;369:1861-8. (Pubitemid 46829356)